Naproxen Sodium
- Product NDC
- 51316-417
- 11-digit product format
- 513160417
- Labeler code
- 51316
- Product ID
- 51316-417_01b06900-15bc-4867-a347-d5f0101d4fb8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
- Application
- ANDA204872
- Marketing category
- ANDA
- Marketing start
- 2021-11-04
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51316-417-08 | 51316041708 | 1 BOTTLE, PLASTIC in 1 CARTON (51316-417-08) > 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | 2021-11-04 | 0000-00-00 | No | No | Current |
| 51316-417-15 | 51316041715 | 1 BOTTLE, PLASTIC in 1 CARTON (51316-417-15) > 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | 2021-11-04 | 0000-00-00 | No | No | Current |